Shawn Cross
CIK: 0001734779
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Apr 23, 2026PCRX
Pacira BioSciences, Inc.
Sale(S)Direct12.9K shares at avg. $25.16$326K - Apr 23, 2026PCRX
Pacira BioSciences, Inc.
Exercise(M)Direct12.9K shares at avg. $16.45$213K - Apr 22, 2026PCRX
Pacira BioSciences, Inc.
Sale(S)Direct1.5K shares at avg. $25.01$38K - Apr 22, 2026PCRX
Pacira BioSciences, Inc.
Exercise(M)Direct1.5K shares at avg. $16.45$25K - Apr 21, 2026PCRX
Pacira BioSciences, Inc.
Sale(S)Direct2.8K shares at avg. $25.01$71K - Apr 21, 2026PCRX
Pacira BioSciences, Inc.
Exercise(M)Direct2.8K shares at avg. $16.45$47K - Apr 20, 2026PCRX
Pacira BioSciences, Inc.
Exercise(M)Direct7.7K shares at avg. $16.45$127K - Apr 20, 2026PCRX
Pacira BioSciences, Inc.
Sale(S)Direct7.7K shares at avg. $25.14$194K - Feb 11, 2026PCRX
Pacira BioSciences, Inc.
Award(A)Direct49.1K shares- - Dec 10, 2025PCRX
Pacira BioSciences, Inc.
Sale(S)Direct9.1K shares at avg. $25.14$229K - Dec 10, 2025PCRX
Pacira BioSciences, Inc.
Exercise(M)Direct9.1K shares at avg. $16.45$150K - Dec 9, 2025PCRX
Pacira BioSciences, Inc.
Exercise(M)Direct15.9K shares at avg. $16.45$261K - Dec 9, 2025PCRX
Pacira BioSciences, Inc.
Sale(S)Direct15.9K shares at avg. $25.03$398K - Nov 10, 2025PCRX
Pacira BioSciences, Inc.
Sale(S)Direct12.1K shares at avg. $22.09$266K - Oct 31, 2025PCRX
Pacira BioSciences, Inc.
Tax Payment(F)Direct6.7K shares at avg. $21.38$143K - Feb 27, 2025CYTH
Cyclo Therapeutics, Inc.
Award(A)Direct28.6K shares- - Nov 15, 2024CYTH
Cyclo Therapeutics, Inc.
Award(A)Direct17.2K shares- - Nov 4, 2024PCRX
Pacira BioSciences, Inc.
Award(A)DirectStock Option (Right to Buy)
200K shares- - Nov 1, 2024PCRX
Pacira BioSciences, Inc.
Award(A)Direct75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 23, 2026 |  PCRX Pacira BioSciences, Inc. | Sale(S) | 12,941 | $25.16 | $325,596 | Direct |
| Apr 23, 2026 | PCRX Pacira BioSciences, Inc. | Exercise(M) | 12,941 | $16.45 | $212,879 | Direct |
| Apr 22, 2026 | PCRX Pacira BioSciences, Inc. | Sale(S) | 1,500 | $25.01 | $37,515 | Direct |
| Apr 22, 2026 | PCRX Pacira BioSciences, Inc. | Exercise(M) | 1,500 | $16.45 | $24,675 | Direct |
| Apr 21, 2026 | PCRX Pacira BioSciences, Inc. | Sale(S) | 2,845 | $25.01 | $71,153 | Direct |
| Apr 21, 2026 | PCRX Pacira BioSciences, Inc. | Exercise(M) | 2,845 | $16.45 | $46,800 | Direct |
| Apr 20, 2026 | PCRX Pacira BioSciences, Inc. | Exercise(M) | 7,714 | $16.45 | $126,895 | Direct |
| Apr 20, 2026 | PCRX Pacira BioSciences, Inc. | Sale(S) | 7,714 | $25.14 | $193,930 | Direct |
| Feb 11, 2026 | PCRX Pacira BioSciences, Inc. | Award(A) | 49,091 | - | $0 | Direct |
| Dec 10, 2025 | PCRX Pacira BioSciences, Inc. | Sale(S) | 9,104 | $25.14 | $228,875 | Direct |
| Dec 10, 2025 | PCRX Pacira BioSciences, Inc. | Exercise(M) | 9,104 | $16.45 | $149,761 | Direct |
| Dec 9, 2025 | PCRX Pacira BioSciences, Inc. | Exercise(M) | 15,896 | $16.45 | $261,489 | Direct |
| Dec 9, 2025 | PCRX Pacira BioSciences, Inc. | Sale(S) | 15,896 | $25.03 | $397,877 | Direct |
| Nov 10, 2025 | PCRX Pacira BioSciences, Inc. | Sale(S) | 12,060 | $22.09 | $266,405 | Direct |
| Oct 31, 2025 | PCRX Pacira BioSciences, Inc. | Tax Payment(F) | 6,690 | $21.38 | $143,032 | Direct |
| Feb 27, 2025 |  CYTH Cyclo Therapeutics, Inc. | Award(A) | 28,597 | - | - | Direct |
| Nov 15, 2024 | CYTH Cyclo Therapeutics, Inc. | Award(A) | 17,228 | - | $0 | Direct |
| Nov 4, 2024 | PCRX Pacira BioSciences, Inc. | Award(A) Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| Nov 1, 2024 | PCRX Pacira BioSciences, Inc. | Award(A) | 75,000 | - | $0 | Direct |
1-19 of 19 transactions
About Cross Shawn
Cross Shawn (SEC CIK 0001734779) files insider reports with the SEC as Chief Financial Officer of Pacira BioSciences, Inc. (PCRX) and Director of Cyclo Therapeutics, Inc. (CYTH).
Signal8 holds 10 ownership filings by Cross Shawn (1 Form 3, 9 Form 4), filed between Oct 23, 2024 and Apr 24, 2026. Those filings report 19 transactions, from Nov 1, 2024 to Apr 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cross Shawn's filings is in BRISBANE, CA.
Recent filings by Cross Shawn
- Apr 23, 2026: Open-market sale of PCRX shares (Form 4, code S).
- Apr 23, 2026: Option exercise of PCRX shares (Form 4, code M).
- Apr 22, 2026: Open-market sale of PCRX shares (Form 4, code S).
- Apr 22, 2026: Option exercise of PCRX shares (Form 4, code M).
- Apr 21, 2026: Open-market sale of PCRX shares (Form 4, code S).
Other insiders filing for Pacira BioSciences, Inc. (PCRX)
- RIKER LAUREN, Senior Vice President, Finance
- SLONIN JONATHAN, Chief Medical Officer
- Hirawat Samit, Director
- CHRISTIE CHRISTOPHER, Director
- WIGGANS THOMAS G, Director
- Young Alethia, Director